Skip to main content

Share story

Science

Physicists push thousands of atoms to a 'Schrödinger's cat' state

An illustration of particles behaving like a wave Image: Primary
Physicists have put nanoparticles of 7,000 sodium atoms into a Schrödinger's cat state. Researchers observed the nanoparticles acting as a cohesive wave. This sets a record for the most macroscopic object in a quantum state. The team produced a beam of sodium nanoparticles and aimed it at a narrow slit. The nanoparticles spread out to produce an interference pattern. This shows wave-particle duality. The results were published Jan. 21 in the journal Nature. Lead study author Sebastian Pedalino, a physicist at the University of Vienna, said quantum mechanics does not state any limits. That is what the team is testing. For two years the team saw only flat lines on the detector. The interference pattern finally appeared late at night. Measurements continued until 3 a.m. when they ran out of sodium. The nanoparticles reached a macroscopicity of 15.5. This beats the previous record by an order of magnitude. The discovery opens the door for future experiments with biological materials such as a virus or proteins.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from livescience.com and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.